Superpower peptides available for pre-order. Get first access.

Not FDA-approved

Brain & sleep

Epitalon

Also called epithalon, epithalamin

EvidenceLimited research
ClassPineal tetrapeptide (Ala-Glu-Asp-Gly)

Key takeaway

Epitalon is a synthetic four-amino acid peptide based on a pineal-gland extract, studied for aging and sleep-related markers. Its human evidence comes from three small studies in older adults, night-shift workers, and people with an inherited retinal disease. As of October 2026 it is still not FDA-approved, but an interim HHS policy covers conditional 503A compounding of epitalon acetate for subcutaneous or intramuscular injection in intermittent courses while rulemaking remains pending.

Published
April 18, 2026
Last updated
November 13, 2026

At a glance

What it isSynthetic pineal tetrapeptide (Ala-Glu-Asp-Gly) marketed for longevity; a different substance from the pineal extract epithalamin
FDA statusNot FDA-approved; HHS interim enforcement discretion covers epitalon acetate for subcutaneous or intramuscular injection in intermittent courses under conditions; notice published October 30, 2026
ResearchMostly cell and animal work; small human studies measured melatonin markers and retinal function
Evidence strengthLimited research
US accessConditional, prescription-based compounding under an interim HHS policy, which is not FDA approval; Superpower's waitlist is open

What is epitalon?

Epitalon, also spelled epithalon, is a synthetic peptide of four amino acids: alanine, glutamic acid, aspartic acid, and glycine (AEDG). Researchers built it from the amino-acid makeup of epithalamin1, a cattle pineal-gland extract containing a mix of peptides. FDA treats the two as different substances2, so findings on the extract do not describe epitalon. Epitalon is sold through wellness and "research peptide" channels for anti-aging, longevity, and sleep, often as a "peptide bioregulator."

Benefits of epitalon under study

Epitalon research centers on aging, and most findings come from cells and animals:

Learn more about epitalon benefits under study

What does the research show?

Human research on synthetic epitalon includes three small studies:

Telomeres and lifespan have no published human studies yet; the melatonin studies give future trials a starting point.

Side effects and safety

FDA's adverse-event database held no epitalon reports through December 8, 20252, and FDA's 2026 review found no clinical data to support epitalon's safety in humans. The human studies were not dedicated safety studies: the older-adult and retinal reports describe no side effects, and the night-shift study did not report safety data. Female mice given epitalon for life showed no change in overall tumor incidence8. FDA also found the ingredient not well characterized and named sterility as a critical safety factor for injected products.

Learn more about epitalon side effects

Epitalon dosage and forms

No standard epitalon dose exists, and FDA found no pharmacokinetic (absorption and clearance) data. Human studies used 0.01 mg a day injected into a muscle14 for 10 days, 0.5 mg a day as an under-the-tongue spray2 for 20 days, and 5 µg per eye a day13 injected around the eye for 10 days. Websites FDA reviewed described 5 mg to 10 mg a day2, injected under the skin or swallowed; these are reported practice patterns rather than a standardized dose. Swallowed epitalon has been studied in rats1, not people. For a prescribed product, the clinician sets the dose.

Learn more about epitalon dosage

How does epitalon work?

Proposed mechanisms come from cell and animal studies. Researchers link epitalon to the pineal gland's daily melatonin rhythm15, and in the night-shift study it shifted the activity of clock genes, which time the body's daily cycle, in blood cells. Other proposed actions are switching on telomerase, the enzyme that extends telomeres, and lowering oxidative stress, cell damage caused by reactive oxygen molecules. These are proposed mechanisms, and controlled human studies would test whether they carry over to health outcomes.

Is epitalon FDA-approved?

No. Epitalon is not approved by the FDA for any use, and its compounding status changed in 2026:

  • July 2026: FDA's Pharmacy Compounding Advisory Committee gave epitalon a narrow, non-binding favorable vote toward the 503A compounding list.
  • October 30, 2026: HHS published an interim enforcement-discretion policy16 covering epitalon acetate for subcutaneous or intramuscular injection in intermittent courses. Conditions include a patient-specific prescription, ingredients from an FDA-registered manufacturer, documented quality testing, and a single active ingredient. Rulemaking is still pending, and the policy is separate from FDA approval and from findings about clinical safety or effectiveness.

Learn more about Epitalon and the FDA

Getting epitalon in 2026

Superpower will offer epitalon formulated in FDA-registered facilities in the US, backed by third-party lab testing, and distributed from US-licensed pharmacies. A licensed clinician will assess whether epitalon fits each person's health care. Anyone interested can join the Superpower peptide waitlist now.

Epitalon is not an FDA-approved drug. Under the October 2026 HHS policy, the government does not intend to take enforcement action17 against state-licensed pharmacies compounding epitalon and five other peptides18 under conditions that include FDA-registered ingredient sources and a patient-specific prescription. It followed a July 2026 FDA advisory committee recommendation to add epitalon19 to the 503A Bulks List, and rulemaking on that list continues.

Where can I learn about peptides?

Superpower’s peptide library covers epitalon and related peptides, each guide written and fact-checked by a team of health journalists and licensed clinicians.

The science behind peptides explains how peptides are made, studied, and regulated, helpful context for the small human studies and long-running animal research behind epitalon.

More for brain & sleep